Los Angeles Capital Management’s Astrana Health ASTH Stock Holding History

Los Angeles Capital Management’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.95K	Sell	202 -9,006	-98%	-$213K	﹤0.01%	2132
2025 Q4	$293K	Buy	+9,208	New	+$245K	﹤0.01%	1112
2023 Q3	–	Sell	-10,088	Closed	-$319K	–	1253
2023 Q2	$319K	Buy	10,088 +175	+2%	+$6K	﹤0.01%	977
2023 Q1	$362K	Sell	9,913 -36,160	-78%	-$1.27M	﹤0.01%	956
2022 Q4	$1.36M	Buy	46,073 +12,610	+38%	+$405K	0.01%	616
2022 Q3	$1.3M	Buy	+33,463	New	+$1.53M	0.01%	613

Other funds holding ASTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Los Angeles Capital Management's ASTH Position: Q1 2026 in Review

Los Angeles Capital Management reduced its Astrana Health (ASTH) stake by 98% in Q1 2026, selling an estimated $213K and leaving 202 shares worth $4.95K. The position accounts for ﹤0.01% of the portfolio, ranked #2132.

Los Angeles Capital Management first reported a position in ASTH in Q3 2022 and has held it in 6 quarters since. The position peaked at $1.36M in Q4 2022. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

Los Angeles Capital Management held 202 shares of Astrana Health worth $4.95K as of Q1 2026.
Los Angeles Capital Management sold 9,006 Astrana Health shares in Q1 2026, an estimated $213K.
Astrana Health made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #2132 holding.
Los Angeles Capital Management first reported a position in Astrana Health in Q3 2022 and has held it in 6 quarters since.
Los Angeles Capital Management's Astrana Health position peaked at $1.36M in Q4 2022.
171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.